---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256493995.md"
description: "A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%"
datetime: "2025-09-09T06:19:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256493995.md)
  - [en](https://longbridge.com/en/news/256493995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256493995.md)
---

# 

A-shares of innovative drug concept stocks fluctuated and fell, with InventisBio dropping over 10%. Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and BaiLi Tianheng also saw declines of more than 6%

### Related Stocks

- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)
- [603127.CN](https://longbridge.com/en/quote/603127.CN.md)
- [06127.HK](https://longbridge.com/en/quote/06127.HK.md)
- [688382.CN](https://longbridge.com/en/quote/688382.CN.md)
- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)
- [688222.CN](https://longbridge.com/en/quote/688222.CN.md)

## Related News & Research

- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)
- [07:45 ETIU Health launches theranostics center of excellence to expand personalized treatments for patients with cancer](https://longbridge.com/en/news/296350151.md)
- [BioArctic, Mesenkia partner to develop BrainTransporter-enabled antibody for glioblastoma](https://longbridge.com/en/news/296330014.md)
- [PharmaTher selects PD Labs as US center of excellence for PERSONALIZ3D platform commercialization](https://longbridge.com/en/news/296225346.md)
- [BioNxt completes IMPD, moves toward first human bioequivalence trial for sublingual cladribine film in MS](https://longbridge.com/en/news/296314929.md)